13F filer · CIK 1792126
Logos Global Management LP
San Francisco, CA · filing since Q4 2019 · last filing Aug 14, 2026
Reported value
$2.3B
+$320.0M vs prior
Positions
68
New / sold out
25 / 23
Added / reduced
18 / 19
Turnover
43.9%
buys $949.6M · sells $1.0B
Top-10 weight
48.3%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | BIONTECH SE | +1,015,000 | – | +$94.4M |
| New | VERA THERAPEUTICS INC | +2,200,000 | – | +$94.4M |
| Added | CELLDEX THERAPEUTICS INC NEW | +1,650,000 | +366.7% | +$61.4M |
| Added | ABIVAX SA | +349,000 | +51.7% | +$46.5M |
| Added | DIANTHUS THERAPEUTICS INC | +400,000 | +100.0% | +$39.0M |
| New | BELITE BIO INC | +250,000 | – | +$38.5M |
| New | ACHIEVE LIFE SCIENCE INC | +5,425,000 | – | +$35.4M |
| New | COGENT BIOSCIENCES INC | +900,000 | – | +$34.8M |
| New | COMPASS PATHWAYS PLC | +2,250,000 | – | +$31.8M |
| Added | CG ONCOLOGY INC | +425,000 | +73.9% | +$30.2M |
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | REVOLUTION MEDICINES INC | -1,300,000 | -65.0% | $-243.5M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -2,125,000 | -100.0% | $-84.4M |
| Sold out | TERNS PHARMACEUTICALS INC | -1,500,000 | -100.0% | $-79.1M |
| Sold out | CYTOKINETICS INC | -875,000 | -100.0% | $-57.7M |
| Sold out | UNITED THERAPEUTICS CORP DEL | -80,000 | -100.0% | $-47.4M |
| Sold out | MADRIGAL PHARMACEUTICALS INC | -85,000 | -100.0% | $-44.5M |
| Sold out | BIOGEN INC | -200,000 | -100.0% | $-36.7M |
| Reduced | RHYTHM PHARMACEUTICALS INC | -325,000 | -72.2% | $-36.1M |
| Sold out | TYRA BIOSCIENCES INC | -850,000 | -100.0% | $-32.6M |
| Reduced | IMMUNOCORE HLDGS PLC | -900,000 | -60.0% | $-28.6M |
32 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | ERASCA INCCOM | 12,150,000 | $222.6M | 9.58% |
| 2 | ABIVAX SASPONSORED ADS | 1,024,000 | $136.5M | 5.87% |
| 3 | REVOLUTION MEDICINES INCCOM | 700,000 | $131.1M | 5.64% |
| 4 | IDEAYA BIOSCIENCES INCCOM | 3,000,000 | $111.8M | 4.81% |
| 5 | BIONTECH SESPONSORED ADS | 1,015,000 | $94.4M | 4.07% |
| 6 | VERA THERAPEUTICS INCCL A | 2,200,000 | $94.4M | 4.06% |
| 7 | TANGO THERAPEUTICS INCCOM | 2,850,000 | $89.1M | 3.84% |
| 8 | PRAXIS PRECISION MEDICINES ICOM NEW | 260,000 | $87.0M | 3.75% |
| 9 | CELLDEX THERAPEUTICS INC NEWCOM NEW | 2,100,000 | $78.1M | 3.36% |
| 10 | DIANTHUS THERAPEUTICS INCCOM | 800,000 | $78.0M | 3.36% |
58 more rows. Subscribe for $29/month to see every row, download the data and use the API.